The Supreme Court has granted the Justice Department's request to leave in place the FDA's approval of the widely used abortion pill mifepristone, preserving access to the drug and reinstating steps that make it easier to obtain. This decision is a victory for abortion rights advocates, who argued that the restrictions on the drug were medically unnecessary. The case is expected to be heard by the full 5th Circuit Court of Appeals in the coming months.
